3rd Quarter - Amendment

BROWNSTEIN HYATT FARBER SCHRECK, LLP for JOHNSON & JOHNSON SERVICES, INC.

Firm
Client
Income
$90,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2016 $90,000 Replaced
3rd Quarter - Amendment (this page) Nov 22, 2016 $90,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

Issues related to legal reform

LobbyistCovered position, as disclosed
ALEXANDER DAHL —
WILLIAM MOSCHELLA —
ALFRED MOTTUR —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; U.S. Agency for International Development (USAID); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Issues related to corporate tax issues Issues related to tax reform Tax extenders

LobbyistCovered position, as disclosed
MICHAEL B LEVY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); White House Office; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

H.R. 9 - Innovation Act S. 632 - STRONG Patents Act of 2015

LobbyistCovered position, as disclosed
ALEXANDER DAHL —
WILLIAM MOSCHELLA —
ALFRED MOTTUR —
BRIAN WILD —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID)

Bills named: S. 632 (114th), H.R. 9 (114th)

Health Issues HCR

Issues related to drug shortage Issues related to 340B drug discount program Issues related to incentivizing antibiotics Use of medical devices Issues related to AIDS Research and development funding for responding to pandemics (Ebola and Zika) Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects Issues related to expanded access

Contacted: Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; White House Office

Consumer Issues/Safety/Products CSP

Issues related to contact lens pricing Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products S. 524 Comprehensive Addiction and Recovery Act of 2016 H.R. 953 Comprehensive Addiction and Recovery Act of 2015

LobbyistCovered position, as disclosed
CATE MCCANLESS BLANKENBURG —
LAURA JOHNSON BOLLIER —
ALEXANDER DAHL —
ELIZABETH ANNE MAIER —
ALFRED MOTTUR —

Contacted: Commerce, Dept of (DOC); White House Office; HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 524 (114th), H.R. 953 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.